<i>Clostridium difficile</i> and gut health: Bacteria, the gut microbiome, and diet

<i>Clostridium difficile</i> infection (CDI) is a growing global health threat, presenting significant challenges to public health. Advances in metabolomics and proteomics have enhanced our understanding of human physiology, particularly the influence of gut microbiota and dietary components on diseases like CDI. This review explores recent insights into CDI pathogenesis, including the infection cycle, toxin mechanisms, spore structure, germination, and therapeutic strategies targeting spore formation and germination. We also examine the role of gut microbiota and metabolites in CDI progression, along with the impact of diet on disease pathology through microbiota modulation and immune regulation. We aim to guide the development of precise, individualized dietary strategies to regulate gut microbiota and immune responses, offering innovative therapeutic options for CDI prevention.

Authors

Institutions

Publication Details

Journal
iMetaOmics.
Published
2024-12-31
DOI
https://doi.org/10.1002/imo2.50
Citations
6
Primary Topic
Clostridium difficile and Clostridium perfringens research
Type
article
Field-Weighted Citation Impact
2.33

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clostridium difficile and gut health: Bacteria, the gut microbiome, and diet

Junhu Yao, Javier Villafuerte-Gálvez, Hua Xu, Xinru Ma et al.
6 citations
iMetaOmics.
Clostridium difficile and Clostridium perfringens research
2.33
article

Clostridium difficile and gut health: Bacteria, the gut microbiome, and diet

Junhu Yao, Javier Villafuerte-Gálvez, Hua Xu, Xinru Ma, Yangchun Cao, Shengru Wu, Xinhua Chen, Lamei Wang, Hao Yang
article en
6 citations

Abstract

<i>Clostridium difficile</i> infection (CDI) is a growing global health threat, presenting significant challenges to public health. Advances in metabolomics and proteomics have enhanced our understanding of human physiology, particularly the influence of gut microbiota and dietary components on diseases like CDI. This review explores recent insights into CDI pathogenesis, including the infection cycle, toxin mechanisms, spore structure, germination, and therapeutic strategies targeting spore formation and germination. We also examine the role of gut microbiota and metabolites in CDI progression, along with the impact of diet on disease pathology through microbiota modulation and immune regulation. We aim to guide the development of precise, individualized dietary strategies to regulate gut microbiota and immune responses, offering innovative therapeutic options for CDI prevention.

iMetaOmics.Vol. 2(1)
Beth Israel Deaconess Medical Center (US), Harvard University (US), Northwest A&F University (CN)
National Natural Science Foundation of China, National Key Research and Development Program of China
Good health and well-being
Openalex Percentile: Top 11%
Clostridium difficile and Clostridium perfringens research
2.33
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

<i>Clostridium difficile</i> and gut health: Bacteria, the gut microbiome, and diet — Junhu Yao, Javier Villafuerte-Gálvez, et al. · iMetaOmics. (2024) | TGRS Research Map | TGRS